Home > Insider Trading > Filing (0001209191-15-065325)

Filing Details

Accession Number:: 0001209191-15-065325
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-11 17:34:15
Reporting Period:: 2015-08-07

Filing Date:: 2015-08-11
Accepted Time:: 2015-08-11 17:34:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-08-07	1,310	$0.00	2,960	No	4	A	Direct
Ordinary Shares	Disposition	2015-08-10	797	$179.98	2,163	No	4	S	Direct
Ordinary Shares	Disposition	2015-08-10	4	$183.36	2,159	No	4	S	Direct
Ordinary Shares	Disposition	2015-08-10	196	$180.05	284,108	No	4	S	Indirect	By Longitude Venture Partners, L.P.
Ordinary Shares	Disposition	2015-08-10	7,362	$181.71	276,746	No	4	S	Indirect	By Longitude Venture Partners, L.P.
Ordinary Shares	Disposition	2015-08-10	1,177	$182.68	275,569	No	4	S	Indirect	By Longitude Venture Partners, L.P.
Ordinary Shares	Disposition	2015-08-10	1,069	$183.77	274,500	No	4	S	Indirect	By Longitude Venture Partners, L.P.
Ordinary Shares	Disposition	2015-08-10	4	$180.05	5,692	No	4	S	Indirect	By Longitude Capital Associates, L.P.
Ordinary Shares	Disposition	2015-08-10	148	$181.71	5,544	No	4	S	Indirect	By Longitude Capital Associates, L.P.
Ordinary Shares	Disposition	2015-08-10	23	$182.69	5,521	No	4	S	Indirect	By Longitude Capital Associates, L.P.
Ordinary Shares	Disposition	2015-08-10	21	$183.75	5,500	No	4	S	Indirect	By Longitude Capital Associates, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Longitude Venture Partners, L.P.
No	4	S	Indirect	By Longitude Venture Partners, L.P.
No	4	S	Indirect	By Longitude Venture Partners, L.P.
No	4	S	Indirect	By Longitude Venture Partners, L.P.
No	4	S	Indirect	By Longitude Capital Associates, L.P.
No	4	S	Indirect	By Longitude Capital Associates, L.P.
No	4	S	Indirect	By Longitude Capital Associates, L.P.
No	4	S	Indirect	By Longitude Capital Associates, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Nonstatutory Stock Option (right to buy)	Acquisiton	2015-08-07	3,415	$0.00	3,415	$181.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,415		2025-08-06	No	4	A	Direct

Footnotes

These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2016.
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Sale effected pursuant to a Rule 10b5-1 trading plan.
The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and LongitudeCapital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and LongitudeCapital Associates, L.P. except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.33 to $182.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.35 to $183.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.45 to $184.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.45 to $184.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
This option is granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vests in 12 equal monthly installments beginning on August 1, 2015.